Incidence of human parvovirus B19 DNA detection in blood donors
- 1 December 1995
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 91 (4) , 1017-1018
- https://doi.org/10.1111/j.1365-2141.1995.tb05427.x
Abstract
Summary. 1000 serum samples from blood donors were tested for human parvovirus B19 (B19) DNA by a nested PCR assay: six samples were positive for B19 DNA. The frequency was 1/167 (0-6%), considerably higher than previous surveys (0-004-0-03%). Five of the six samples were also positive for anti-B19 IgM, indicating an acute phase of infection. It is recommended to screen for B19 DNA in blood products to prevent transfusion mediated viral infection for those susceptible such as immunocompromised patients and pregnant women.Keywords
This publication has 12 references indexed in Scilit:
- Human parvovirus B19 infection in Kawasaki diseaseThe Lancet, 1994
- B19 parvovirus DNA in solvent/detergent-treated anti-haemophilia concentratesThe Lancet, 1994
- Thrombocytopenia induced by human parvovirus B19 infectionsEuropean Journal of Haematology, 1993
- Retrospective Study on the Influence of Human Parvovirus B19 Infection among Children with Malignant DiseasesActa Haematologica, 1993
- Human parvovirus B19 in clotting factor concentrates: B19 DNA detection by the nested polymerase chain reactionBritish Journal of Haematology, 1992
- Human parvovirus B19 infection in hemophiliacs first infused with two high‐purity, virally attenuated factor Vlll concentratesAmerican Journal of Hematology, 1992
- A rapid method of sample preparation for detection of DNA viruses in human serum by polymerase chain reactionJournal of Virological Methods, 1991
- Blood donor screening for parvovirus B19Journal of Virological Methods, 1990
- Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentratesJournal of Medical Virology, 1988
- TRANSMISSION OF SERUM PARVOVIRUS-LIKE VIRUS BY CLOTTING-FACTOR CONCENTRATESThe Lancet, 1983